//
Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration
The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction
New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial
High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome